Calluna Pharma Inc.

About Calluna Pharma Inc.

Calluna Pharma is a global biotech company focused on fibrosis and inflammation, driven by a committed team. They aim to redefine the approach to targeting inflammation and fibrosis with innovative therapeutics to change patients' lives worldwide.

Products & Services

Clinical-stage antibodies:First-in-class antibodies targeting indications of high unmet need and strategic importance.

Aurora IPF Phase 2 Study:A specific study focused on idiopathic pulmonary fibrosis (IPF) in Phase 2.

Specialties

Fibrosis Inflammation Upstream disease amplifiers Clinical-stage antibodies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 75000000 MR: - FA: 75 million FAN: 75000000	D: 2024-01-23 FD: 2024-01-23	4 investors

Series A Latest

2024-01-23

$75.0M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Mark Gaffney

Chief Executive Officer and member of the Board

J

Jonas Hallén

Chief Medical Officer

C

Caroline Kurtz

Chief Scientific Officer

M

Margrethe Sørgaard

SVP Clinical Operations and Pharmacovigilance

B

Berte Poulsson

SVP Operations

M

Mark Altmeyer

Chairperson

View 8 more team members with Pro

Unlock Full Team Directory

Recent News